Brief: Helix Biopharma Welcomes Daniel Von Hoff, Kazimierz Roszkowski-Sliz And Robert Gillies To Its Scientific And Strategic Advisory Board
22/03/2018 12:05
March 22 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP WELCOMES DRS. DANIEL VON HOFF,
KAZIMIERZ
ROSZKOWSKI-SLIZ AND ROBERT GILLIES TO ITS SCIENTIFIC AND
STRATEGIC ADVISORY BOARD
Source text for Eikon: ID:nGNX66G1f9
Further company coverage: HBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020